Industry Research Reports

Part 1

Part 2

Part 3

Part 4

Part 5

Home > Reports > Medical Devices & Consumables > Global Hepatitis A Viruses Rapid Testing Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032

Global Hepatitis A Viruses Rapid Testing Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032

Industry: Medical Devices & Consumables

Published: 2026-03-12

Pages: 109 Pages

Report ld: 6224287

Request Sample

Pre-Order Enquiry

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description

The global Hepatitis A Viruses Rapid Testing market size was US$ 1613 million in 2025 and is forecast to reach a readjusted size of US$ 2101 million by 2032 with a CAGR of 3.9% during the forecast period 2026-2032.

Hepatitis A Virus (HAV) Rapid Test is a point-of-care in vitro diagnostic technique that detects hepatitis A virus antigens or antibodies in human samples (e.g., serum, plasma, whole blood, or stool) within a short time frame (typically 15-30 minutes) using immunological principles such as colloidal gold or lateral flow immunoassay. Its primary purpose is to rapidly screen for acute or past HAV infections. This test is characterized by its simplicity, instrument-free operation, and suitability for primary healthcare settings, emergency scenarios, or infectious disease control in resource-limited areas.

Hepatitis A Viruses Rapid Testing Market Size(US$)

M= millions and B=billions

In 2025, the North America Hepatitis A Viruses Rapid Testing market was US$ million, while the Europe market stood at US$ million. North America accounted for % of the global market in 2025 and Europe for %. Europe’s share is expected to reach % by 2032, corresponding to a CAGR of % over the analysis period.

Major global manufacturers of Hepatitis A Viruses Rapid Testing include Roche Diagnostics, Abbott Rapid Diagnostics, GSK, Merck, Sanofi, Sinovac, Zhejiang Pukang, Changchun Institute of Biological, KM Biologics, IMBCA, among others. In 2025, the top five players accounted for approximately % of global market revenue.

In terms of sales volume, the top three players in North America accounted for about % of the market in 2025, while the top three in Europe held nearly %.

The global Hepatitis A Viruses Rapid Testing market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on sales, revenue, and forecasts across regions, by Type, and by Application for 2021-2032.

Market Segmentation

Report Metric
Details
Report Title
Global Hepatitis A Viruses Rapid Testing Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
Forecasted Market Size in 2032
US$ 2101 million
CAGR(2026-2032)
3.9%
Market Size Available for Years
2026-2032
Global Hepatitis A Viruses Rapid Testing Companies Covered
Roche Diagnostics
Abbott Rapid Diagnostics
GSK
Merck
Sanofi
Sinovac
Zhejiang Pukang
Changchun Institute of Biological
KM Biologics
IMBCA
ChangSheng
Convac
Bio-Rad Laboratories
Wondfo
Wantai Bio
Siemens Healthineers
Global Hepatitis A Viruses Rapid Testing Market, by Region
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Hepatitis A Viruses Rapid Testing Market, Segment by Type
Blood Tests
Non-Blood Tests
Global Hepatitis A Viruses Rapid Testing Market, Segment by Application
Hospital
Clinic
Forecast Units
Million USD
Report Coverage
Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline
Chapter 1: Report scope, segment-level executive summary (by Type, by Application) and market evolution across the short, mid and long term
Chapter 2: Quantitative analysis of Hepatitis A Viruses Rapid Testing sales and revenue at global, regional, and country levels, highlighting market size and growth potential by region
Chapter 3: Competitive landscape of Hepatitis A Viruses Rapid Testing manufacturers (sales, revenue, pricing, market share, industry rankings, and M&A / expansion plans)
Chapter 4: by Type-based segmentation analysis (sales, revenue, pricing, and growth potential) to identify blue-ocean product segments
Chapter 5: by Application-based segmentation analysis (sales, revenue, pricing, and growth potential) to uncover high-value downstream markets
Chapter 6: Regional breakdown by company, customer, by Type and by Application (sales, revenue, and pricing for each segment)
Chapter 7: Key manufacturer profiles –company overview, Hepatitis A Viruses Rapid Testing product descriptions and specifications, revenue, gross margins, and recent developments
Chapter 8: Industry chain analysis – upstream raw materials, manufacturing links, and downstream application sectors
Chapter 9: Sales channels and distributor analysis – routes to market and key customer interfaces
Chapter 10: Market dynamics – trends, drivers, restraints, risks for manufacturers, and the impact of relevant industry policies
Chapter 11: Key findings, main takeaways, and overall conclusions of the report.
Why This Report?
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Hepatitis A Viruses Rapid Testing value chain, addressing:
- Market entry risks/opportunities by region
- Product mix optimization based on local practices
- Competitor tactics in fragmented vs. consolidated markets

Table of Contents

1 Market Overview
    1.1 Hepatitis A Viruses Rapid Testing Product Scope
    1.2 Hepatitis A Viruses Rapid Testing by Type
        1.2.1 Global Hepatitis A Viruses Rapid Testing Sales by Type (2021, 2025 & 2032)
        1.2.2 Blood Tests
        1.2.3 Non-Blood Tests
    1.3 Hepatitis A Viruses Rapid Testing by Application
        1.3.1 Global Hepatitis A Viruses Rapid Testing Sales Comparison by Application (2021, 2025 & 2032)
        1.3.2 Hospital
        1.3.3 Clinic
    1.4 Global Hepatitis A Viruses Rapid Testing Market Estimates and Forecasts (2021-2032)
        1.4.1 Global Hepatitis A Viruses Rapid Testing Market Size (Value) and Growth Rate (2021-2032)
        1.4.2 Global Hepatitis A Viruses Rapid Testing Market Size (Volume) and Growth Rate (2021-2032)
        1.4.3 Global Hepatitis A Viruses Rapid Testing Price Trends (2021-2032)
    1.5 Assumptions and Limitations

2 Market Size and Prospects by Region
    2.1 Global Hepatitis A Viruses Rapid Testing Market Size by Region: 2021 VS 2025 VS 2032
    2.2 Global Hepatitis A Viruses Rapid Testing Historical Market Scenario by Region (2021-2026)
        2.2.1 Global Hepatitis A Viruses Rapid Testing Sales Market Share by Region (2021-2026)
        2.2.2 Global Hepatitis A Viruses Rapid Testing Revenue Market Share by Region (2021-2026)
    2.3 Global Hepatitis A Viruses Rapid Testing Market Estimates and Forecasts by Region (2027-2032)
        2.3.1 Global Hepatitis A Viruses Rapid Testing Sales Estimates and Forecasts by Region (2027-2032)
        2.3.2 Global Hepatitis A Viruses Rapid Testing Revenue Forecast by Region (2027-2032)
    2.4 Major Regions and Emerging Market Analysis
        2.4.1 North America Hepatitis A Viruses Rapid Testing Market Size and Prospects (2021-2032)
        2.4.2 Europe Hepatitis A Viruses Rapid Testing Market Size and Prospects (2021-2032)
        2.4.3 China Hepatitis A Viruses Rapid Testing Market Size and Prospects (2021-2032)
        2.4.4 Japan Hepatitis A Viruses Rapid Testing Market Size and Prospects (2021-2032)

3 Global Market Size by Type
    3.1 Global Hepatitis A Viruses Rapid Testing Historical Market Review by Type (2021-2026)
        3.1.1 Global Hepatitis A Viruses Rapid Testing Sales by Type (2021-2026)
        3.1.2 Global Hepatitis A Viruses Rapid Testing Revenue by Type (2021-2026)
        3.1.3 Global Hepatitis A Viruses Rapid Testing Average Price by Type (2021-2026)
    3.2 Global Hepatitis A Viruses Rapid Testing Market Estimates and Forecasts by Type (2027-2032)
        3.2.1 Global Hepatitis A Viruses Rapid Testing Sales Forecast by Type (2027-2032)
        3.2.2 Global Hepatitis A Viruses Rapid Testing Revenue Forecast by Type (2027-2032)
        3.2.3 Global Hepatitis A Viruses Rapid Testing Price Forecast by Type (2027-2032)
    3.3 Representative Players for Different Types of Hepatitis A Viruses Rapid Testing

4 Global Market Size by Application
    4.1 Global Hepatitis A Viruses Rapid Testing Historical Market Review by Application (2021-2026)
        4.1.1 Global Hepatitis A Viruses Rapid Testing Sales by Application (2021-2026)
        4.1.2 Global Hepatitis A Viruses Rapid Testing Revenue by Application (2021-2026)
        4.1.3 Global Hepatitis A Viruses Rapid Testing Average Price by Application (2021-2026)
    4.2 Global Hepatitis A Viruses Rapid Testing Market Estimates and Forecasts by Application (2027-2032)
        4.2.1 Global Hepatitis A Viruses Rapid Testing Sales Forecast by Application (2027-2032)
        4.2.2 Global Hepatitis A Viruses Rapid Testing Revenue Forecast by Application (2027-2032)
        4.2.3 Global Hepatitis A Viruses Rapid Testing Price Forecast by Application (2027-2032)
    4.3 New Sources of Growth in Hepatitis A Viruses Rapid Testing Applications

5 Competition Landscape by Players
    5.1 Global Hepatitis A Viruses Rapid Testing Sales by Player (2021-2026)
    5.2 Global Top Hepatitis A Viruses Rapid Testing Players by Revenue (2021-2026)
    5.3 Global Hepatitis A Viruses Rapid Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3), based on Hepatitis A Viruses Rapid Testing revenue as of 2025
    5.4 Global Hepatitis A Viruses Rapid Testing Average Price by Company (2021-2026)
    5.5 Global Key Manufacturers of Hepatitis A Viruses Rapid Testing, Manufacturing Sites & Headquarters
    5.6 Global Key Manufacturers of Hepatitis A Viruses Rapid Testing, Product Type & Application
    5.7 Global Key Manufacturers of Hepatitis A Viruses Rapid Testing, Date of Entry into This Industry
    5.8 Manufacturers Mergers & Acquisitions, Expansion Plans

6 Regional Analysis
    6.1 North America Market: Players, Segments, Downstream and Major Customers
        6.1.1 North America Hepatitis A Viruses Rapid Testing Sales by Company
            6.1.1.1 North America Hepatitis A Viruses Rapid Testing Sales by Company (2021-2026)
            6.1.1.2 North America Hepatitis A Viruses Rapid Testing Revenue by Company (2021-2026)
        6.1.2 North America Hepatitis A Viruses Rapid Testing Sales Breakdown by Type (2021-2026)
        6.1.3 North America Hepatitis A Viruses Rapid Testing Sales Breakdown by Application (2021-2026)
        6.1.4 North America Hepatitis A Viruses Rapid Testing Major Customers
        6.1.5 North America Market Trends and Opportunities
    6.2 Europe Market: Players, Segments, Downstream and Major Customers
        6.2.1 Europe Hepatitis A Viruses Rapid Testing Sales by Company
            6.2.1.1 Europe Hepatitis A Viruses Rapid Testing Sales by Company (2021-2026)
            6.2.1.2 Europe Hepatitis A Viruses Rapid Testing Revenue by Company (2021-2026)
        6.2.2 Europe Hepatitis A Viruses Rapid Testing Sales Breakdown by Type (2021-2026)
        6.2.3 Europe Hepatitis A Viruses Rapid Testing Sales Breakdown by Application (2021-2026)
        6.2.4 Europe Hepatitis A Viruses Rapid Testing Major Customers
        6.2.5 Europe Market Trends and Opportunities
    6.3 China Market: Players, Segments, Downstream and Major Customers
        6.3.1 China Hepatitis A Viruses Rapid Testing Sales by Company
            6.3.1.1 China Hepatitis A Viruses Rapid Testing Sales by Company (2021-2026)
            6.3.1.2 China Hepatitis A Viruses Rapid Testing Revenue by Company (2021-2026)
        6.3.2 China Hepatitis A Viruses Rapid Testing Sales Breakdown by Type (2021-2026)
        6.3.3 China Hepatitis A Viruses Rapid Testing Sales Breakdown by Application (2021-2026)
        6.3.4 China Hepatitis A Viruses Rapid Testing Major Customers
        6.3.5 China Market Trends and Opportunities
    6.4 Japan Market: Players, Segments, Downstream and Major Customers
        6.4.1 Japan Hepatitis A Viruses Rapid Testing Sales by Company
            6.4.1.1 Japan Hepatitis A Viruses Rapid Testing Sales by Company (2021-2026)
            6.4.1.2 Japan Hepatitis A Viruses Rapid Testing Revenue by Company (2021-2026)
        6.4.2 Japan Hepatitis A Viruses Rapid Testing Sales Breakdown by Type (2021-2026)
        6.4.3 Japan Hepatitis A Viruses Rapid Testing Sales Breakdown by Application (2021-2026)
        6.4.4 Japan Hepatitis A Viruses Rapid Testing Major Customers
        6.4.5 Japan Market Trends and Opportunities

7 Company Profiles and Key Figures
    7.1 Roche Diagnostics
        7.1.1 Roche Diagnostics Company Information
        7.1.2 Roche Diagnostics Business Overview
        7.1.3 Roche Diagnostics Hepatitis A Viruses Rapid Testing Sales, Revenue and Gross Margin (2021-2026)
        7.1.4 Roche Diagnostics Hepatitis A Viruses Rapid Testing Products Offered
        7.1.5 Roche Diagnostics Recent Development
    7.2 Abbott Rapid Diagnostics
        7.2.1 Abbott Rapid Diagnostics Company Information
        7.2.2 Abbott Rapid Diagnostics Business Overview
        7.2.3 Abbott Rapid Diagnostics Hepatitis A Viruses Rapid Testing Sales, Revenue and Gross Margin (2021-2026)
        7.2.4 Abbott Rapid Diagnostics Hepatitis A Viruses Rapid Testing Products Offered
        7.2.5 Abbott Rapid Diagnostics Recent Development
    7.3 GSK
        7.3.1 GSK Company Information
        7.3.2 GSK Business Overview
        7.3.3 GSK Hepatitis A Viruses Rapid Testing Sales, Revenue and Gross Margin (2021-2026)
        7.3.4 GSK Hepatitis A Viruses Rapid Testing Products Offered
        7.3.5 GSK Recent Development
    7.4 Merck
        7.4.1 Merck Company Information
        7.4.2 Merck Business Overview
        7.4.3 Merck Hepatitis A Viruses Rapid Testing Sales, Revenue and Gross Margin (2021-2026)
        7.4.4 Merck Hepatitis A Viruses Rapid Testing Products Offered
        7.4.5 Merck Recent Development
    7.5 Sanofi
        7.5.1 Sanofi Company Information
        7.5.2 Sanofi Business Overview
        7.5.3 Sanofi Hepatitis A Viruses Rapid Testing Sales, Revenue and Gross Margin (2021-2026)
        7.5.4 Sanofi Hepatitis A Viruses Rapid Testing Products Offered
        7.5.5 Sanofi Recent Development
    7.6 Sinovac
        7.6.1 Sinovac Company Information
        7.6.2 Sinovac Business Overview
        7.6.3 Sinovac Hepatitis A Viruses Rapid Testing Sales, Revenue and Gross Margin (2021-2026)
        7.6.4 Sinovac Hepatitis A Viruses Rapid Testing Products Offered
        7.6.5 Sinovac Recent Development
    7.7 Zhejiang Pukang
        7.7.1 Zhejiang Pukang Company Information
        7.7.2 Zhejiang Pukang Business Overview
        7.7.3 Zhejiang Pukang Hepatitis A Viruses Rapid Testing Sales, Revenue and Gross Margin (2021-2026)
        7.7.4 Zhejiang Pukang Hepatitis A Viruses Rapid Testing Products Offered
        7.7.5 Zhejiang Pukang Recent Development
    7.8 Changchun Institute of Biological
        7.8.1 Changchun Institute of Biological Company Information
        7.8.2 Changchun Institute of Biological Business Overview
        7.8.3 Changchun Institute of Biological Hepatitis A Viruses Rapid Testing Sales, Revenue and Gross Margin (2021-2026)
        7.8.4 Changchun Institute of Biological Hepatitis A Viruses Rapid Testing Products Offered
        7.8.5 Changchun Institute of Biological Recent Development
    7.9 KM Biologics
        7.9.1 KM Biologics Company Information
        7.9.2 KM Biologics Business Overview
        7.9.3 KM Biologics Hepatitis A Viruses Rapid Testing Sales, Revenue and Gross Margin (2021-2026)
        7.9.4 KM Biologics Hepatitis A Viruses Rapid Testing Products Offered
        7.9.5 KM Biologics Recent Development
    7.10 IMBCA
        7.10.1 IMBCA Company Information
        7.10.2 IMBCA Business Overview
        7.10.3 IMBCA Hepatitis A Viruses Rapid Testing Sales, Revenue and Gross Margin (2021-2026)
        7.10.4 IMBCA Hepatitis A Viruses Rapid Testing Products Offered
        7.10.5 IMBCA Recent Development
    7.11 ChangSheng
        7.11.1 ChangSheng Company Information
        7.11.2 ChangSheng Business Overview
        7.11.3 ChangSheng Hepatitis A Viruses Rapid Testing Sales, Revenue and Gross Margin (2021-2026)
        7.11.4 ChangSheng Hepatitis A Viruses Rapid Testing Products Offered
        7.11.5 ChangSheng Recent Development
    7.12 Convac
        7.12.1 Convac Company Information
        7.12.2 Convac Business Overview
        7.12.3 Convac Hepatitis A Viruses Rapid Testing Sales, Revenue and Gross Margin (2021-2026)
        7.12.4 Convac Hepatitis A Viruses Rapid Testing Products Offered
        7.12.5 Convac Recent Development
    7.13 Bio-Rad Laboratories
        7.13.1 Bio-Rad Laboratories Company Information
        7.13.2 Bio-Rad Laboratories Business Overview
        7.13.3 Bio-Rad Laboratories Hepatitis A Viruses Rapid Testing Sales, Revenue and Gross Margin (2021-2026)
        7.13.4 Bio-Rad Laboratories Hepatitis A Viruses Rapid Testing Products Offered
        7.13.5 Bio-Rad Laboratories Recent Development
    7.14 Wondfo
        7.14.1 Wondfo Company Information
        7.14.2 Wondfo Business Overview
        7.14.3 Wondfo Hepatitis A Viruses Rapid Testing Sales, Revenue and Gross Margin (2021-2026)
        7.14.4 Wondfo Hepatitis A Viruses Rapid Testing Products Offered
        7.14.5 Wondfo Recent Development
    7.15 Wantai Bio
        7.15.1 Wantai Bio Company Information
        7.15.2 Wantai Bio Business Overview
        7.15.3 Wantai Bio Hepatitis A Viruses Rapid Testing Sales, Revenue and Gross Margin (2021-2026)
        7.15.4 Wantai Bio Hepatitis A Viruses Rapid Testing Products Offered
        7.15.5 Wantai Bio Recent Development
    7.16 Siemens Healthineers
        7.16.1 Siemens Healthineers Company Information
        7.16.2 Siemens Healthineers Business Overview
        7.16.3 Siemens Healthineers Hepatitis A Viruses Rapid Testing Sales, Revenue and Gross Margin (2021-2026)
        7.16.4 Siemens Healthineers Hepatitis A Viruses Rapid Testing Products Offered
        7.16.5 Siemens Healthineers Recent Development

8 Hepatitis A Viruses Rapid Testing Manufacturing Cost Analysis
    8.1 Hepatitis A Viruses Rapid Testing Key Raw Materials Analysis
        8.1.1 Key Raw Materials
        8.1.2 Key Suppliers of Raw Materials
    8.2 Manufacturing Cost Structure
    8.3 Manufacturing Process Analysis of Hepatitis A Viruses Rapid Testing
    8.4 Hepatitis A Viruses Rapid Testing Industrial Chain Analysis

9 Marketing Channels, Distributors and Customers
    9.1 Marketing Channels
    9.2 Hepatitis A Viruses Rapid Testing Distributors List
    9.3 Hepatitis A Viruses Rapid Testing Customers

10 Hepatitis A Viruses Rapid Testing Market Dynamics
    10.1 Hepatitis A Viruses Rapid Testing Industry Trends
    10.2 Hepatitis A Viruses Rapid Testing Market Drivers
    10.3 Hepatitis A Viruses Rapid Testing Market Challenges
    10.4 Hepatitis A Viruses Rapid Testing Market Restraints

11 Research Findings and Conclusion

12 Appendix
    12.1 Research Methodology
        12.1.1 Methodology/Research Approach
            12.1.1.1 Research Programs/Design
            12.1.1.2 Market Size Estimation
            12.1.1.3 Market Breakdown and Data Triangulation
        12.1.2 Data Source
            12.1.2.1 Secondary Sources
            12.1.2.2 Primary Sources
    12.2 Author Details
    12.3 Disclaimer

Table of Figures

List of Tables
 Table 1. Global Hepatitis A Viruses Rapid Testing Sales (US$ Million) Growth Rate by Type (2021, 2025 & 2032)
 Table 2. Global Hepatitis A Viruses Rapid Testing Sales (US$ Million) Comparison by Application (2021, 2025 & 2032)
 Table 3. Global Market Hepatitis A Viruses Rapid Testing Market Size (US$ Million) by Region:2021 VS 2025 VS 2032
 Table 4. Global Hepatitis A Viruses Rapid Testing Sales (K Units) by Region (2021-2026)
 Table 5. Global Hepatitis A Viruses Rapid Testing Sales Market Share by Region (2021-2026)
 Table 6. Global Hepatitis A Viruses Rapid Testing Revenue (US$ Million) Market Share by Region (2021-2026)
 Table 7. Global Hepatitis A Viruses Rapid Testing Revenue Share by Region (2021-2026)
 Table 8. Global Hepatitis A Viruses Rapid Testing Sales (K Units) Forecast by Region (2027-2032)
 Table 9. Global Hepatitis A Viruses Rapid Testing Sales Market Share Forecast by Region (2027-2032)
 Table 10. Global Hepatitis A Viruses Rapid Testing Revenue (US$ Million) Forecast by Region (2027-2032)
 Table 11. Global Hepatitis A Viruses Rapid Testing Revenue Share Forecast by Region (2027-2032)
 Table 12. Global Hepatitis A Viruses Rapid Testing Sales by Type (K Units) & (2021-2026)
 Table 13. Global Hepatitis A Viruses Rapid Testing Sales Share by Type (2021-2026)
 Table 14. Global Hepatitis A Viruses Rapid Testing Revenue by Type (US$ Million) & (2021-2026)
 Table 15. Global Hepatitis A Viruses Rapid Testing Average Price by Type (US$/Unit) & (2021-2026)
 Table 16. Global Hepatitis A Viruses Rapid Testing Sales by Type (K Units) & (2027-2032)
 Table 17. Global Hepatitis A Viruses Rapid Testing Revenue by Type (US$ Million) & (2027-2032)
 Table 18. Global Hepatitis A Viruses Rapid Testing Average Price by Type (US$/Unit) & (2027-2032)
 Table 19. Representative Players of Each Type
 Table 20. Global Hepatitis A Viruses Rapid Testing Sales by Application (K Units) & (2021-2026)
 Table 21. Global Hepatitis A Viruses Rapid Testing Sales Share by Application (2021-2026)
 Table 22. Global Hepatitis A Viruses Rapid Testing Revenue by Application (US$ Million) & (2021-2026)
 Table 23. Global Hepatitis A Viruses Rapid Testing Average Price by Application (US$/Unit) & (2021-2026)
 Table 24. Global Hepatitis A Viruses Rapid Testing Sales by Application (K Units) & (2027-2032)
 Table 25. Global Hepatitis A Viruses Rapid Testing Revenue Market Share by Application (US$ Million) & (2027-2032)
 Table 26. Global Hepatitis A Viruses Rapid Testing Average Price by Application (US$/Unit) & (2027-2032)
 Table 27. New Sources of Growth in Hepatitis A Viruses Rapid Testing Applications
 Table 28. Global Hepatitis A Viruses Rapid Testing Sales by Company (K Units) & (2021-2026)
 Table 29. Global Hepatitis A Viruses Rapid Testing Sales Share by Company (2021-2026)
 Table 30. Global Hepatitis A Viruses Rapid Testing Revenue by Company (US$ Million) & (2021-2026)
 Table 31. Global Hepatitis A Viruses Rapid Testing Revenue Share by Company (2021-2026)
 Table 32. Global Hepatitis A Viruses Rapid Testing by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hepatitis A Viruses Rapid Testing as of 2025)
 Table 33. Global Market Hepatitis A Viruses Rapid Testing Average Price by Company (US$/Unit) & (2021-2026)
 Table 34. Global Key Manufacturers of Hepatitis A Viruses Rapid Testing, Manufacturing Sites & Headquarters
 Table 35. Global Key Manufacturers of Hepatitis A Viruses Rapid Testing, Product Type & Application
 Table 36. Global Key Manufacturers of Hepatitis A Viruses Rapid Testing, Date of Entry into This Industry
 Table 37. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 38. North America Hepatitis A Viruses Rapid Testing Sales by Company (2021-2026) & (K Units)
 Table 39. North America Hepatitis A Viruses Rapid Testing Sales Market Share by Company (2021-2026)
 Table 40. North America Hepatitis A Viruses Rapid Testing Revenue by Company (2021-2026) & (US$ Million)
 Table 41. North America Hepatitis A Viruses Rapid Testing Revenue Market Share by Company (2021-2026)
 Table 42. North America Hepatitis A Viruses Rapid Testing Sales by Type (2021-2026) & (K Units)
 Table 43. North America Hepatitis A Viruses Rapid Testing Sales Market Share by Type (2021-2026)
 Table 44. North America Hepatitis A Viruses Rapid Testing Sales by Application (2021-2026) & (K Units)
 Table 45. North America Hepatitis A Viruses Rapid Testing Sales Market Share by Application (2021-2026)
 Table 46. Europe Hepatitis A Viruses Rapid Testing Sales by Company (2021-2026) & (K Units)
 Table 47. Europe Hepatitis A Viruses Rapid Testing Sales Market Share by Company (2021-2026)
 Table 48. Europe Hepatitis A Viruses Rapid Testing Revenue by Company (2021-2026) & (US$ Million)
 Table 49. Europe Hepatitis A Viruses Rapid Testing Revenue Market Share by Company (2021-2026)
 Table 50. Europe Hepatitis A Viruses Rapid Testing Sales by Type (2021-2026) & (K Units)
 Table 51. Europe Hepatitis A Viruses Rapid Testing Sales Market Share by Type (2021-2026)
 Table 52. Europe Hepatitis A Viruses Rapid Testing Sales by Application (2021-2026) & (K Units)
 Table 53. Europe Hepatitis A Viruses Rapid Testing Sales Market Share by Application (2021-2026)
 Table 54. China Hepatitis A Viruses Rapid Testing Sales by Company (2021-2026) & (K Units)
 Table 55. China Hepatitis A Viruses Rapid Testing Sales Market Share by Company (2021-2026)
 Table 56. China Hepatitis A Viruses Rapid Testing Revenue by Company (2021-2026) & (US$ Million)
 Table 57. China Hepatitis A Viruses Rapid Testing Revenue Market Share by Company (2021-2026)
 Table 58. China Hepatitis A Viruses Rapid Testing Sales by Type (2021-2026) & (K Units)
 Table 59. China Hepatitis A Viruses Rapid Testing Sales Market Share by Type (2021-2026)
 Table 60. China Hepatitis A Viruses Rapid Testing Sales by Application (2021-2026) & (K Units)
 Table 61. China Hepatitis A Viruses Rapid Testing Sales Market Share by Application (2021-2026)
 Table 62. Japan Hepatitis A Viruses Rapid Testing Sales by Company (2021-2026) & (K Units)
 Table 63. Japan Hepatitis A Viruses Rapid Testing Sales Market Share by Company (2021-2026)
 Table 64. Japan Hepatitis A Viruses Rapid Testing Revenue by Company (2021-2026) & (US$ Million)
 Table 65. Japan Hepatitis A Viruses Rapid Testing Revenue Market Share by Company (2021-2026)
 Table 66. Japan Hepatitis A Viruses Rapid Testing Sales by Type (2021-2026) & (K Units)
 Table 67. Japan Hepatitis A Viruses Rapid Testing Sales Market Share by Type (2021-2026)
 Table 68. Japan Hepatitis A Viruses Rapid Testing Sales by Application (2021-2026) & (K Units)
 Table 69. Japan Hepatitis A Viruses Rapid Testing Sales Market Share by Application (2021-2026)
 Table 70. Roche Diagnostics Company Information
 Table 71. Roche Diagnostics Description and Business Overview
 Table 72. Roche Diagnostics Hepatitis A Viruses Rapid Testing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
 Table 73. Roche Diagnostics Hepatitis A Viruses Rapid Testing Product
 Table 74. Roche Diagnostics Recent Development
 Table 75. Abbott Rapid Diagnostics Company Information
 Table 76. Abbott Rapid Diagnostics Description and Business Overview
 Table 77. Abbott Rapid Diagnostics Hepatitis A Viruses Rapid Testing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
 Table 78. Abbott Rapid Diagnostics Hepatitis A Viruses Rapid Testing Product
 Table 79. Abbott Rapid Diagnostics Recent Development
 Table 80. GSK Company Information
 Table 81. GSK Description and Business Overview
 Table 82. GSK Hepatitis A Viruses Rapid Testing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
 Table 83. GSK Hepatitis A Viruses Rapid Testing Product
 Table 84. GSK Recent Development
 Table 85. Merck Company Information
 Table 86. Merck Description and Business Overview
 Table 87. Merck Hepatitis A Viruses Rapid Testing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
 Table 88. Merck Hepatitis A Viruses Rapid Testing Product
 Table 89. Merck Recent Development
 Table 90. Sanofi Company Information
 Table 91. Sanofi Description and Business Overview
 Table 92. Sanofi Hepatitis A Viruses Rapid Testing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
 Table 93. Sanofi Hepatitis A Viruses Rapid Testing Product
 Table 94. Sanofi Recent Development
 Table 95. Sinovac Company Information
 Table 96. Sinovac Description and Business Overview
 Table 97. Sinovac Hepatitis A Viruses Rapid Testing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
 Table 98. Sinovac Hepatitis A Viruses Rapid Testing Product
 Table 99. Sinovac Recent Development
 Table 100. Zhejiang Pukang Company Information
 Table 101. Zhejiang Pukang Description and Business Overview
 Table 102. Zhejiang Pukang Hepatitis A Viruses Rapid Testing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
 Table 103. Zhejiang Pukang Hepatitis A Viruses Rapid Testing Product
 Table 104. Zhejiang Pukang Recent Development
 Table 105. Changchun Institute of Biological Company Information
 Table 106. Changchun Institute of Biological Description and Business Overview
 Table 107. Changchun Institute of Biological Hepatitis A Viruses Rapid Testing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
 Table 108. Changchun Institute of Biological Hepatitis A Viruses Rapid Testing Product
 Table 109. Changchun Institute of Biological Recent Development
 Table 110. KM Biologics Company Information
 Table 111. KM Biologics Description and Business Overview
 Table 112. KM Biologics Hepatitis A Viruses Rapid Testing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
 Table 113. KM Biologics Hepatitis A Viruses Rapid Testing Product
 Table 114. KM Biologics Recent Development
 Table 115. IMBCA Company Information
 Table 116. IMBCA Description and Business Overview
 Table 117. IMBCA Hepatitis A Viruses Rapid Testing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
 Table 118. IMBCA Hepatitis A Viruses Rapid Testing Product
 Table 119. IMBCA Recent Development
 Table 120. ChangSheng Company Information
 Table 121. ChangSheng Description and Business Overview
 Table 122. ChangSheng Hepatitis A Viruses Rapid Testing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
 Table 123. ChangSheng Hepatitis A Viruses Rapid Testing Product
 Table 124. ChangSheng Recent Development
 Table 125. Convac Company Information
 Table 126. Convac Description and Business Overview
 Table 127. Convac Hepatitis A Viruses Rapid Testing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
 Table 128. Convac Hepatitis A Viruses Rapid Testing Product
 Table 129. Convac Recent Development
 Table 130. Bio-Rad Laboratories Company Information
 Table 131. Bio-Rad Laboratories Description and Business Overview
 Table 132. Bio-Rad Laboratories Hepatitis A Viruses Rapid Testing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
 Table 133. Bio-Rad Laboratories Hepatitis A Viruses Rapid Testing Product
 Table 134. Bio-Rad Laboratories Recent Development
 Table 135. Wondfo Company Information
 Table 136. Wondfo Description and Business Overview
 Table 137. Wondfo Hepatitis A Viruses Rapid Testing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
 Table 138. Wondfo Hepatitis A Viruses Rapid Testing Product
 Table 139. Wondfo Recent Development
 Table 140. Wantai Bio Company Information
 Table 141. Wantai Bio Description and Business Overview
 Table 142. Wantai Bio Hepatitis A Viruses Rapid Testing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
 Table 143. Wantai Bio Hepatitis A Viruses Rapid Testing Product
 Table 144. Wantai Bio Recent Development
 Table 145. Siemens Healthineers Company Information
 Table 146. Siemens Healthineers Description and Business Overview
 Table 147. Siemens Healthineers Hepatitis A Viruses Rapid Testing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
 Table 148. Siemens Healthineers Hepatitis A Viruses Rapid Testing Product
 Table 149. Siemens Healthineers Recent Development
 Table 150. Production Base and Market Concentration Rate of Raw Material
 Table 151. Key Suppliers of Raw Materials
 Table 152. Hepatitis A Viruses Rapid Testing Distributors List
 Table 153. Hepatitis A Viruses Rapid Testing Customers List
 Table 154. Hepatitis A Viruses Rapid Testing Market Trends
 Table 155. Hepatitis A Viruses Rapid Testing Market Drivers
 Table 156. Hepatitis A Viruses Rapid Testing Market Challenges
 Table 157. Hepatitis A Viruses Rapid Testing Market Restraints
 Table 158. Research Programs/Design for This Report
 Table 159. Key Data Information from Secondary Sources
 Table 160. Key Data Information from Primary Sources


List of Figures
 Figure 1. Hepatitis A Viruses Rapid Testing Product Picture
 Figure 2. Global Hepatitis A Viruses Rapid Testing Sales (US$ Million) by Type (2021, 2025 & 2032)
 Figure 3. Global Hepatitis A Viruses Rapid Testing Sales Market Share by Type in 2025 & 2032
 Figure 4. Blood Tests Product Picture
 Figure 5. Non-Blood Tests Product Picture
 Figure 6. Global Hepatitis A Viruses Rapid Testing Sales (US$ Million) by Application (2021, 2025 & 2032)
 Figure 7. Global Hepatitis A Viruses Rapid Testing Sales Market Share by Application in 2025 & 2032
 Figure 8. Hospital Examples
 Figure 9. Clinic Examples
 Figure 10. Global Hepatitis A Viruses Rapid Testing Sales, (US$ Million), 2021 VS 2025 VS 2032
 Figure 11. Global Hepatitis A Viruses Rapid Testing Sales Growth Rate (2021-2032) & (US$ Million)
 Figure 12. Global Hepatitis A Viruses Rapid Testing Sales (K Units) Growth Rate (2021-2032)
 Figure 13. Global Hepatitis A Viruses Rapid Testing Price Trends Growth Rate (2021-2032) & (US$/Unit)
 Figure 14. Hepatitis A Viruses Rapid Testing Report Years Considered
 Figure 15. Global Market Hepatitis A Viruses Rapid Testing Market Size (US$ Million) by Region:2021 VS 2025 VS 2032
 Figure 16. Global Hepatitis A Viruses Rapid Testing Revenue Market Share by Region: 2021 VS 2025
 Figure 17. North America Hepatitis A Viruses Rapid Testing Revenue (US$ Million) Growth Rate (2021-2032)
 Figure 18. North America Hepatitis A Viruses Rapid Testing Sales (K Units) Growth Rate (2021-2032)
 Figure 19. Europe Hepatitis A Viruses Rapid Testing Revenue (US$ Million) Growth Rate (2021-2032)
 Figure 20. Europe Hepatitis A Viruses Rapid Testing Sales (K Units) Growth Rate (2021-2032)
 Figure 21. China Hepatitis A Viruses Rapid Testing Revenue (US$ Million) Growth Rate (2021-2032)
 Figure 22. China Hepatitis A Viruses Rapid Testing Sales (K Units) Growth Rate (2021-2032)
 Figure 23. Japan Hepatitis A Viruses Rapid Testing Revenue (US$ Million) Growth Rate (2021-2032)
 Figure 24. Japan Hepatitis A Viruses Rapid Testing Sales (K Units) Growth Rate (2021-2032)
 Figure 25. Global Hepatitis A Viruses Rapid Testing Revenue Share by Type (2021-2026)
 Figure 26. Global Hepatitis A Viruses Rapid Testing Sales Share by Type (2027-2032)
 Figure 27. Global Hepatitis A Viruses Rapid Testing Revenue Share by Type (2027-2032)
 Figure 28. Global Hepatitis A Viruses Rapid Testing Revenue Share by Application (2021-2026)
 Figure 29. Global Hepatitis A Viruses Rapid Testing Revenue Market Share by Application in 2021 & 2025
 Figure 30. Global Hepatitis A Viruses Rapid Testing Sales Share by Application (2027-2032)
 Figure 31. Global Hepatitis A Viruses Rapid Testing Revenue Share by Application (2027-2032)
 Figure 32. Global Hepatitis A Viruses Rapid Testing Sales Share by Company (2025)
 Figure 33. Global Hepatitis A Viruses Rapid Testing Revenue Share by Company (2025)
 Figure 34. Global 5 Largest Hepatitis A Viruses Rapid Testing Players Market Share by Revenue in Hepatitis A Viruses Rapid Testing: 2021 & 2025
 Figure 35. Hepatitis A Viruses Rapid Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025
 Figure 36. Manufacturing Cost Structure of Hepatitis A Viruses Rapid Testing
 Figure 37. Manufacturing Process Analysis of Hepatitis A Viruses Rapid Testing
 Figure 38. Hepatitis A Viruses Rapid Testing Industrial Chain
 Figure 39. Channels of Distribution (Direct Vs Distribution)
 Figure 40. Distributors Profiles
 Figure 41. Bottom-up and Top-down Approaches for This Report
 Figure 42. Data Triangulation
 Figure 43. Key Executives Interviewed

Description

The global Hepatitis A Viruses Rapid Testing market size was US$ 1613 million in 2025 and is forecast to reach a readjusted size of US$ 2101 million by 2032 with a CAGR of 3.9% during the forecast period 2026-2032.

Hepatitis A Virus (HAV) Rapid Test is a point-of-care in vitro diagnostic technique that detects hepatitis A virus antigens or antibodies in human samples (e.g., serum, plasma, whole blood, or stool) within a short time frame (typically 15-30 minutes) using immunological principles such as colloidal gold or lateral flow immunoassay. Its primary purpose is to rapidly screen for acute or past HAV infections. This test is characterized by its simplicity, instrument-free operation, and suitability for primary healthcare settings, emergency scenarios, or infectious disease control in resource-limited areas.

In 2025, the North America Hepatitis A Viruses Rapid Testing market was US$ million, while the Europe market stood at US$ million. North America accounted for % of the global market in 2025 and Europe for %. Europe’s share is expected to reach % by 2032, corresponding to a CAGR of % over the analysis period.

Major global manufacturers of Hepatitis A Viruses Rapid Testing include Roche Diagnostics, Abbott Rapid Diagnostics, GSK, Merck, Sanofi, Sinovac, Zhejiang Pukang, Changchun Institute of Biological, KM Biologics, IMBCA, among others. In 2025, the top five players accounted for approximately % of global market revenue.

In terms of sales volume, the top three players in North America accounted for about % of the market in 2025, while the top three in Europe held nearly %.

The global Hepatitis A Viruses Rapid Testing market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on sales, revenue, and forecasts across regions, by Type, and by Application for 2021-2032.

Market Segmentation

Chapter Outline
Chapter 1: Report scope, segment-level executive summary (by Type, by Application) and market evolution across the short, mid and long term
Chapter 2: Quantitative analysis of Hepatitis A Viruses Rapid Testing sales and revenue at global, regional, and country levels, highlighting market size and growth potential by region
Chapter 3: Competitive landscape of Hepatitis A Viruses Rapid Testing manufacturers (sales, revenue, pricing, market share, industry rankings, and M&A / expansion plans)
Chapter 4: by Type-based segmentation analysis (sales, revenue, pricing, and growth potential) to identify blue-ocean product segments
Chapter 5: by Application-based segmentation analysis (sales, revenue, pricing, and growth potential) to uncover high-value downstream markets
Chapter 6: Regional breakdown by company, customer, by Type and by Application (sales, revenue, and pricing for each segment)
Chapter 7: Key manufacturer profiles –company overview, Hepatitis A Viruses Rapid Testing product descriptions and specifications, revenue, gross margins, and recent developments
Chapter 8: Industry chain analysis – upstream raw materials, manufacturing links, and downstream application sectors
Chapter 9: Sales channels and distributor analysis – routes to market and key customer interfaces
Chapter 10: Market dynamics – trends, drivers, restraints, risks for manufacturers, and the impact of relevant industry policies
Chapter 11: Key findings, main takeaways, and overall conclusions of the report.
Why This Report?
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Hepatitis A Viruses Rapid Testing value chain, addressing:
- Market entry risks/opportunities by region
- Product mix optimization based on local practices
- Competitor tactics in fragmented vs. consolidated markets

Related Reports

Global Hepatitis A Viruses Rapid Testing Market Insights, Forecast to 2031
The global Hepatitis A Viruses Rapid Testing market is projected to grow from US$ 1613 million in 2025 to US$ 2029 million by 2031, at a Compound Annual Growth Rate (CAGR) of 3.9% during the forecast period.
Published: 2025-06-26
Pages: 170
USD 4900.00
(Single User License)
Global Hepatitis A Viruses Rapid Testing Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Hepatitis A Viruses Rapid Testing market size was US$ 1553 million in 2024 and is forecast to a readjusted size of US$ 2029 million by 2031 with a CAGR of 3.9% during the forecast period 2025-2031.
Published: 2025-06-26
Pages: 110
USD 4250.00
(Single User License)
Hepatitis A Viruses Rapid Testing - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Hepatitis A Viruses Rapid Testing was estimated to be worth US$ 1553 million in 2024 and is forecast to a readjusted size of US$ 2029 million by 2031 with a CAGR of 3.9% during the forecast period 2025-2031.
Published: 2025-06-26
Pages: 144
USD 3950.00
(Single User License)
Global Hepatitis A Viruses Rapid Testing Market Research Report 2025
The global market for Hepatitis A Viruses Rapid Testing was valued at US$ 1553 million in the year 2024 and is projected to reach a revised size of US$ 2029 million by 2031, growing at a CAGR of 3.9% during the forecast period.
Published: 2025-06-26
Pages: 105
USD 2900.00
(Single User License)
Hepatitis A Viruses Rapid Testing- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Hepatitis A Viruses Rapid Testing was estimated to be worth US$ 1613 million in 2025 and is projected to reach US$ 2101 million, growing at a CAGR of 3.9% from 2026 to 2032.
Published: 2026-03-09
Pages: 144
USD 3950.00
(Single User License)
Global Hepatitis A Viruses Rapid Testing Market Research Report 2026
The global Hepatitis A Viruses Rapid Testing market was valued at US$ 1613 million in 2025 and is anticipated to reach US$ 2101 million by 2032, at a CAGR of 3.9% from 2026 to 2032.
Published: 2026-03-12
Pages: 129
USD 2900.00
(Single User License)
Global Hepatitis A Viruses Rapid Testing Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Hepatitis A Viruses Rapid Testing market is projected to grow from US$ 1613 million in 2025 to US$ 2101 million by 2032, at a CAGR of 3.9% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2026-03-12
Pages: 171
USD 4900.00
(Single User License)

Global Hepatitis A Viruses Rapid Testing Market Insights, Forecast to 2031
The global Hepatitis A Viruses Rapid Testing market is projected to grow from US$ 1613 million in 2025 to US$ 2029 million by 2031, at a Compound Annual Growth Rate (CAGR) of 3.9% during the forecast period.
Published: 2025-06-26
Pages: 170
USD 4900.00 (Single User License)
Global Hepatitis A Viruses Rapid Testing Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Hepatitis A Viruses Rapid Testing market size was US$ 1553 million in 2024 and is forecast to a readjusted size of US$ 2029 million by 2031 with a CAGR of 3.9% during the forecast period 2025-2031.
Published: 2025-06-26
Pages: 110
USD 4250.00 (Single User License)
Hepatitis A Viruses Rapid Testing - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Hepatitis A Viruses Rapid Testing was estimated to be worth US$ 1553 million in 2024 and is forecast to a readjusted size of US$ 2029 million by 2031 with a CAGR of 3.9% during the forecast period 2025-2031.
Published: 2025-06-26
Pages: 144
USD 3950.00 (Single User License)
Global Hepatitis A Viruses Rapid Testing Market Research Report 2025
The global market for Hepatitis A Viruses Rapid Testing was valued at US$ 1553 million in the year 2024 and is projected to reach a revised size of US$ 2029 million by 2031, growing at a CAGR of 3.9% during the forecast period.
Published: 2025-06-26
Pages: 105
USD 2900.00 (Single User License)
Hepatitis A Viruses Rapid Testing- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Hepatitis A Viruses Rapid Testing was estimated to be worth US$ 1613 million in 2025 and is projected to reach US$ 2101 million, growing at a CAGR of 3.9% from 2026 to 2032.
Published: 2026-03-09
Pages: 144
USD 3950.00 (Single User License)
Global Hepatitis A Viruses Rapid Testing Market Research Report 2026
The global Hepatitis A Viruses Rapid Testing market was valued at US$ 1613 million in 2025 and is anticipated to reach US$ 2101 million by 2032, at a CAGR of 3.9% from 2026 to 2032.
Published: 2026-03-12
Pages: 129
USD 2900.00 (Single User License)
Global Hepatitis A Viruses Rapid Testing Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Hepatitis A Viruses Rapid Testing market is projected to grow from US$ 1613 million in 2025 to US$ 2101 million by 2032, at a CAGR of 3.9% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2026-03-12
Pages: 171
USD 4900.00 (Single User License)